Immunogenicity Assessment for Therapeutic Protein Products
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
August 14, 2014
April 24, 2020
04e181cd-8e84-4961-b3ec-443e161c6965
Related Documents
E2F Development Safety Update Report
Guidance DocumentAugust 23, 2011Center for Drug Evaluation and Research
Labeling for Biosimilar Products Guidance for Industry
Guidance DocumentJuly 18, 2018Center for Drug Evaluation and Research
Q11 Development and Manufacture of Drug Substances
Guidance DocumentNovember 20, 2012Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.